1. Home
  2. COLL vs EIG Comparison

COLL vs EIG Comparison

Compare COLL & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • EIG
  • Stock Information
  • Founded
  • COLL 2002
  • EIG 2000
  • Country
  • COLL United States
  • EIG United States
  • Employees
  • COLL N/A
  • EIG N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • EIG Property-Casualty Insurers
  • Sector
  • COLL Health Care
  • EIG Finance
  • Exchange
  • COLL Nasdaq
  • EIG Nasdaq
  • Market Cap
  • COLL 958.8M
  • EIG 970.8M
  • IPO Year
  • COLL 2015
  • EIG 2007
  • Fundamental
  • Price
  • COLL $36.04
  • EIG $42.70
  • Analyst Decision
  • COLL Strong Buy
  • EIG Strong Buy
  • Analyst Count
  • COLL 4
  • EIG 1
  • Target Price
  • COLL $44.25
  • EIG $58.00
  • AVG Volume (30 Days)
  • COLL 463.5K
  • EIG 163.3K
  • Earning Date
  • COLL 11-06-2025
  • EIG 10-29-2025
  • Dividend Yield
  • COLL N/A
  • EIG 3.09%
  • EPS Growth
  • COLL N/A
  • EIG N/A
  • EPS
  • COLL 1.06
  • EIG 4.10
  • Revenue
  • COLL $707,007,000.00
  • EIG $889,500,000.00
  • Revenue This Year
  • COLL $22.23
  • EIG $0.86
  • Revenue Next Year
  • COLL $2.78
  • EIG $0.80
  • P/E Ratio
  • COLL $34.38
  • EIG $10.11
  • Revenue Growth
  • COLL 22.61
  • EIG 2.32
  • 52 Week Low
  • COLL $23.23
  • EIG $38.19
  • 52 Week High
  • COLL $42.29
  • EIG $54.44
  • Technical
  • Relative Strength Index (RSI)
  • COLL 45.96
  • EIG 51.12
  • Support Level
  • COLL $34.71
  • EIG $40.96
  • Resistance Level
  • COLL $36.57
  • EIG $42.48
  • Average True Range (ATR)
  • COLL 1.25
  • EIG 0.66
  • MACD
  • COLL -0.59
  • EIG 0.04
  • Stochastic Oscillator
  • COLL 25.25
  • EIG 68.87

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

Share on Social Networks: